GKWIM
VYGR icon

Gerber Kawasaki Wealth & Investment Management’s Voyager Therapeutics VYGR Stock Holding History

Gerber Kawasaki Wealth & Investment Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10
Closed – – 1108
2021
Q3 		$0 Buy
+10
New +$32 ﹤0.01% 1241

Other funds holding VYGR

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Gerber Kawasaki Wealth & Investment Management's VYGR Position: Q4 2021 in Review

Gerber Kawasaki Wealth & Investment Management sold out of Voyager Therapeutics (VYGR) in Q4 2021, closing a stake of 10 shares.

Gerber Kawasaki Wealth & Investment Management first reported a position in VYGR in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 59 funds tracked by Wall St. Rank hold VYGR as of Q4 2021.

  • Gerber Kawasaki Wealth & Investment Management reported no remaining Voyager Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Gerber Kawasaki Wealth & Investment Management sold 10 Voyager Therapeutics shares in Q4 2021.
  • Gerber Kawasaki Wealth & Investment Management first reported a position in Voyager Therapeutics in Q3 2021 and held it in 1 quarter.
  • Gerber Kawasaki Wealth & Investment Management's Voyager Therapeutics position peaked at $0 in Q3 2021.
  • 59 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q4 2021.

Based on Gerber Kawasaki Wealth & Investment Management's 13F filing for Q4 2021, filed 11 Feb 2022.